Trilla A
Infectious Diseases Unit, Hospital Clinic, University of Barcelona, Spain.
Intensive Care Med. 1994 Jul;20 Suppl 3:S1-4. doi: 10.1007/BF01745243.
Patients in intensive care units (ICUs) are a small subgroup of all hospitalized patients, but they account for approximately 25% of all hospital infections. Nosocomial infection rates among ICU patients are 5-10 times higher than among general ward patients. ICU infection rates are higher due to complex interactions between the patients' underlying disease, severity of illness, type of ICU, duration of stay, and invasive devices used. Antimicrobial resistance is a major clinical problem despite potent and newer antibiotics. Organisms that pose a clinically significant resistance problem among ICU patients include methicillin-resistant staphylococci, enterococci, a wide variety of enterobacteriaceae, Pseudomonas aeruginosa, Pseudomonas cepacia, Xanthomonas maltophila, Acinetobacter and Candida species. Traditional infection control measures include identification of reservoirs, halting transmission between patients, stopping progression from colonization to infection and modifying host risk. In addition, sound selection procedures and guidelines for antibiotic usage are necessary to control the spread of multi-resistant micro-organisms.
重症监护病房(ICU)的患者只是所有住院患者中的一小部分亚组,但他们却占所有医院感染病例的约25%。ICU患者的医院感染率比普通病房患者高出5至10倍。由于患者基础疾病、病情严重程度、ICU类型、住院时间以及所使用的侵入性设备之间存在复杂的相互作用,ICU的感染率更高。尽管有强效和新型抗生素,抗菌药物耐药性仍是一个主要的临床问题。在ICU患者中引起具有临床显著耐药性问题的微生物包括耐甲氧西林葡萄球菌、肠球菌、多种肠杆菌科细菌、铜绿假单胞菌、洋葱伯克霍尔德菌、嗜麦芽窄食单胞菌、不动杆菌属和念珠菌属。传统的感染控制措施包括确定感染源、阻止患者之间的传播、防止从定植发展为感染以及改变宿主风险。此外,为控制多重耐药微生物的传播,合理的抗生素选用程序和指南是必要的。